Thursday, October 6, 2016

Pacnex LP




Generic Name: benzoyl peroxide cleansing pads

Dosage Form: cloth
Pacnex(4.25% Benzoyl Peroxide)LP Cleansing Pads

DESCRIPTION: Pacnex (7% Benzoyl Peroxide) HP Cleansing Pads and Pacnex (4.25% Benzoyl Peroxide) LP Cleansing Pads are intended for topical administration and contain Benzoyl Peroxide for use in the treatment of acne vulgaris.

Benzoyl Peroxide is an oxidizing agent that possesses antibacterial properties and is classified as a keratolytic. Benzoyl Peroxide (C14H10O4) is represented by the following chemical structure:



Each pad of Pacnex HP Cleansing Pads contains 70 mg of Benzoyl Peroxide and Pacnex LP Cleansing Pads contains 42.5 mg of Benzoyl Peroxide in a formulation consisting of: aloe, carbomer interpolymer type A, cetyl alcohol, disodium oleamido MEA-sulfosuccinate, edetate disodium, glycerin, glyceryl stearate and PEG100 stearate, green tea, laureth-12, magnesium aluminum silicate, propylene glycol, purified water, sodium coco-sulfate, sodium lauroamphoacetate, xanthan gum.



CLINICAL PHARMACOLOGY: The mechanism of action of Benzoyl Peroxide is not totally understood but its antibacterial activity against Propionibacterium acnes is thought to be a major mode of action. In addition, patients treated with Benzoyl Peroxide show a reduction in lipids and free fatty acids, and mild desquamation (drying and peeling activity) with simultaneous reduction in comedones and acne lesions. Little is known about the percutaneous penetration, metabolism, and excretion of Benzoyl Peroxide, although it has been shown that Benzoyl Peroxide absorbed by the skin is metabolized to benzoic acid and then excreted as benzoate in the urine. There is no evidence of systemic toxicity caused by Benzoyl Peroxide in humans.



INDICATIONS AND USAGE:

Pacnex HP Cleansing Pads and Pacnex LP Cleansing Pads are indicated for the topical treatment of acne vulgaris.



CONTRAINDICATIONS: These preparations are contraindicated in patients with a history of hypersensitivity to any of their components.



WARNINGS: When using this product, avoid unnecessary sun exposure and use a sunscreen.



PRECAUTIONS: General: For external use only. If severe irritation develops, discontinue use and institute appropriate therapy. After reaction clears, treatment may often be resumed with less frequent application. These preparations should not be used in or near the eyes or on mucous membranes.



Information for Patients: Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. Contact with any colored material (including hair and fabric) may result in bleaching or discoloration. If excessive irritation develops, discontinue use and consult your physician.



Carcinogenesis, Mutagenesis, Impairment of Fertility: Data from several studies employing a strain of mice that is highly susceptible to developing cancer suggest that Benzoyl Peroxide acts as a tumor promoter. The clinical significance of these findings to humans is unknown. Benzoyl Peroxide has not been found to be mutagenic (Ames Test) and there are no published data indicating it impairs fertility.



Pregnancy: Teratogenic Effects: Pregnancy Category C: Animal reproduction studies have not been conducted with Benzoyl Peroxide. It is not known whether Benzoyl Peroxide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Benzoyl Peroxide should be used by a pregnant woman only if clearly needed. There are no available data on the effect of Benzoyl Peroxide on the later growth, development and functional maturation of the unborn child.



Nursing Mothers: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Benzoyl Peroxide is administered to a nursing woman.



Pediatric Use: Safety and effectiveness in children have not been established.



ADVERSE REACTIONS: Allergic contact dermatitis and dryness have been reported with topical Benzoyl Peroxide therapy.



OVERDOSAGE: If excessive scaling, erythema or edema occurs, the use of this preparation should be discontinued. To hasten resolution of the adverse effects, cool compresses may be used. After symptoms and signs subside, a reduced dosage schedule may be cautiously tried if the reaction is judged to be due to excessive use and not allergenicity.



DOSAGE AND ADMINISTRATION: Pacnex (7% Benzoyl Peroxide) HP and Pacnex (4.25% Benzoyl Peroxide) LP: Apply to affected areas once or twice a day, or as directed by your physician. Wet skin and liberally apply to areas to be cleansed. Massage gently into skin for 10-20 seconds, working into a full lather. Rinse thoroughly and pat dry. If excessive drying occurs, control by rinsing off cleanser sooner or using less often.



HOW SUPPLIED:

Pacnex HP Cleansing Pads contain 60 foil pouches, each with a single-use medicated pad (6 g each), NDC 43538-140-60.


Pacnex LP Cleansing Pads contain 60 foil pouches, each with a single-use medicated pad (6 g each), NDC 43538-150-60.



Store at controlled room temperature 15°-30° C (59°-86° F). Protect from freezing.


KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.


Manufactured for:


MEDIMETRIKS

PHARMACEUTICALS, INC.


363 Route 46 West

Fairfield, NJ 07004-2402 USA


www.medimetriks.com



Manufactured by:

Groupe PARIMA, Inc.

Montreal, QC H4S 1X6 CANADA














PACNEX  LP
benzoyl peroxide  cloth










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)43538-150
Route of AdministrationTOPICALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZOYL PEROXIDE (BENZOYL PEROXIDE)BENZOYL PEROXIDE42.5 mg  in 1 g




































Inactive Ingredients
Ingredient NameStrength
ALOE 
CARBOMER INTERPOLYMER TYPE A (55000 CP) 
CETYL ALCOHOL 
DISODIUM OLEAMIDO MEA-SULFOSUCCINATE 
EDETATE DISODIUM 
GLYCERIN 
GLYCERYL MONOSTEARATE 
POLYOXYL 100 STEARATE 
GREEN TEA LEAF 
LAURETH-12 
MAGNESIUM ALUMINUM SILICATE 
PROPYLENE GLYCOL 
WATER 
SODIUM COCO-SULFATE 
SODIUM LAUROAMPHOACETATE 
XANTHAN GUM 


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      














Packaging
#NDCPackage DescriptionMultilevel Packaging
143538-150-6060 POUCH In 1 CARTONcontains a POUCH
16 g In 1 POUCHThis package is contained within the CARTON (43538-150-60)










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other07/09/2010


Labeler - Medimetriks Pharmaceuticals, Inc. (019903816)

Registrant - Groupe PARIMA, Inc. (252437850)









Establishment
NameAddressID/FEIOperations
Groupe PARIMA, Inc.252437850manufacture
Revised: 07/2010Medimetriks Pharmaceuticals, Inc.




More Pacnex LP resources


  • Pacnex LP Side Effects (in more detail)
  • Pacnex LP Use in Pregnancy & Breastfeeding
  • Pacnex LP Drug Interactions
  • Pacnex LP Support Group
  • 0 Reviews for Pacnex LP - Add your own review/rating


  • Acne Treatment Concise Consumer Information (Cerner Multum)

  • Acne Treatment Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • BenzEFoam Foam MedFacts Consumer Leaflet (Wolters Kluwer)

  • Benzac Topical Advanced Consumer (Micromedex) - Includes Dosage Information

  • Benzac AC Wash MedFacts Consumer Leaflet (Wolters Kluwer)

  • Brevoxyl Gel MedFacts Consumer Leaflet (Wolters Kluwer)

  • Brevoxyl Creamy Wash Concise Consumer Information (Cerner Multum)

  • Inova Pads MedFacts Consumer Leaflet (Wolters Kluwer)

  • NeoBenz Micro Wash Plus Pack Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Oxy Balance Topical Advanced Consumer (Micromedex) - Includes Dosage Information

  • PanOxyl Bar MedFacts Consumer Leaflet (Wolters Kluwer)

  • Triaz Cloths MedFacts Consumer Leaflet (Wolters Kluwer)

  • Triazolam Monograph (AHFS DI)



Compare Pacnex LP with other medications


  • Acne
  • Perioral Dermatitis

Prosed EC


Generic Name: atropine, hyoscyamine, methenamine, methylene blue, phenyl salicylate, and benzoic acid (Oral route)


AT-roe-peen SUL-fate, hye-oh-SYE-a-meen SUL-fate, meth-EN-a-meen, METH-i-leen BLOO, FEN-il sal-I-si-late, ben-ZOE-ik AS-id


Commonly used brand name(s)

In the U.S.


  • Prosed EC

  • Trac Tabs

  • Urised

Available Dosage Forms:


  • Tablet

  • Tablet, Enteric Coated

Therapeutic Class: Urinary Antispasmodic


Pharmacologic Class: Atropine


Chemical Class: Salicylate, Non-Aspirin


Uses For Prosed EC


Atropine , hyoscyamine , methenamine , methylene blue, phenyl salicylate , and benzoic acid combination medicine is an anticholinergic, anti-infective, and analgesic. It is given by mouth to help relieve the discomfort caused by urinary tract infections; however, it will not cure the infection itself. This combination medicine may also be used for other conditions as determined by your doctor.


This medicine is available only with your doctor's prescription.


Before Using Prosed EC


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Unusual excitement, nervousness, restlessness or irritability, and unusual warmth, dryness, and flushing of skin are more likely to occur in children, who are usually more sensitive to the effects of atropine and hyoscyamine (contained in this combination medicine). Also, when atropine and hyoscyamine are given to children during hot weather, a rapid increase in body temperature may occur. In infants and children, especially those with spastic paralysis or brain damage, this medicine may be more likely to cause severe side effects.


Geriatric


Confusion or memory loss, constipation, difficult urination, excitement, agitation, drowsiness, or dryness of mouth may be more likely to occur in elderly patients, who are usually more sensitive than younger adults to the effects of atropine and hyoscyamine. Also, this combination medicine may cause eye pain in patients who have untreated glaucoma.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersXStudies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities. This drug should not be used in women who are or may become pregnant because the risk clearly outweighs any possible benefit.

Breast Feeding


Benzoic Acid

Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.


Methylene BlueBenzyl BenzoateMethenamineAtropineHyoscyamine

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Ambenonium

  • Amitriptyline

  • Amoxapine

  • Bupropion

  • Citalopram

  • Clomipramine

  • Desipramine

  • Desvenlafaxine

  • Doxepin

  • Duloxetine

  • Escitalopram

  • Fluoxetine

  • Fluvoxamine

  • Imipramine

  • Isocarboxazid

  • Linezolid

  • Maprotiline

  • Mirtazapine

  • Nortriptyline

  • Paroxetine

  • Phenelzine

  • Potassium

  • Protriptyline

  • Selegiline

  • Sertraline

  • Tranylcypromine

  • Trimipramine

  • Venlafaxine

  • Vilazodone

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Buspirone

  • Nefazodone

  • Trazodone

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Arbutamine

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Bleeding problems (severe)—This combination medicine may increase heart rate, which would make bleeding problems worse

  • Brain damage (in children)—May increase the central nervous system (CNS) effects of this combination medicine

  • Colitis (severe) or

  • Dryness of mouth (severe or continuing) or

  • Enlarged prostate or

  • Fever or

  • Glaucoma or

  • Heart disease or

  • Hernia (hiatal) or

  • High blood pressure or

  • Intestinal blockage or other intestinal or stomach problems or

  • Lung disease or

  • Myasthenia gravis or

  • Toxemia of pregnancy or

  • Urinary tract blockage or difficult urination—This combination medicine may make these conditions worse

  • Dehydration or

  • Kidney disease or

  • Liver disease—Higher levels of medicine may result and increase the risk of side effects

  • Overactive thyroid—May increase the heart rate

Proper Use of atropine, hyoscyamine, methenamine, methylene blue, phenyl salicylate, and benzoic acid

This section provides information on the proper use of a number of products that contain atropine, hyoscyamine, methenamine, methylene blue, phenyl salicylate, and benzoic acid. It may not be specific to Prosed EC. Please read with care.


While you are taking this combination medicine, it is important for your urine to be acidic. To do this, your doctor may recommend that you eat more protein and such foods as cranberries (especially cranberry juice with vitamin C added), plums, or prunes. You should avoid foods that make the urine more alkaline, such as most fruits (especially citrus fruits and juices), milk, and other dairy products.


Take this medicine only as directed. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered. To do so may increase the chance of side effects.


Each dose should be taken with a full glass (8 ounces) of water or other liquid (except citrus juices and milk). Drink plenty of water or other liquids every day, unless otherwise directed by your doctor. Drinking enough liquids will help your kidneys work better and lessen your discomfort.


To help clear up your infection completely, keep taking this medicine for the full time of treatment even if you begin to feel better after a few days. Do not miss any doses.


In order for this medicine to work well, your urine must be acid (pH 5.5 or below). To make sure that your urine is acid:


  • Before you start taking this medicine, check your urine with phenaphthazine paper or another test to see if it is acid. If you have any questions about this, check with your health care professional.

  • You may need to change your diet; however, check with your doctor first if you are on a special diet (for example, for diabetes). To help make your urine more acid you should avoid most fruits (especially citrus fruits and juices), milk and other dairy products, and other foods which make the urine more alkaline. Eating more protein and foods such as cranberries (especially cranberry juice with vitamin C added), plums, or prunes may also help. If your urine is still not acid enough, check with your doctor.

Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (tablets):
    • For relief of urinary tract symptoms:
      • Adults and children 12 years of age and older—1 to 2 tablets four times a day.

      • Children 6 to 12 years of age—Dose must be determined by the doctor.

      • Children up to 6 years of age—Use is not recommended.



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Precautions While Using Prosed EC


If your symptoms do not improve within a few days or if they become worse, check with your doctor.


These medicines may make you sweat less, causing your body temperature to increase. Use extra care not to become overheated during exercise or hot weather while you are taking this medicine, since overheating may result in heat stroke. Also, hot baths or saunas may make you dizzy or faint while you are taking this medicine.


This medicine may cause some people to have blurred vision. Make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are not able to see well. If your vision continues to be blurred, check with your doctor.


This medicine may cause dryness of the mouth. For temporary relief, use sugarless candy or gum, melt bits of ice in your mouth, or use a saliva substitute. However, if your mouth continues to feel dry for more than 2 weeks, check with your dentist. Continuing dryness of the mouth may increase the chance of dental disease, including tooth decay, gum disease, and fungus infections.


Do not take this medicine within 2 or 3 hours of taking antacids or medicine for diarrhea. Taking antacids or antidiarrhea medicines and this medicine too close together may prevent this medicine from working properly.


Prosed EC Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor as soon as possible if any of the following side effects occur:


Less common or rare
  • Blurred vision

  • eye pain

  • skin rash or hives

Symptoms of overdose
  • Blood in urine and/or stools

  • diarrhea

  • dizziness

  • drowsiness (severe)

  • fast heartbeat

  • flushing or redness of face

  • headache (severe or continuing)

  • lower back pain

  • pain or burning while urinating

  • ringing or buzzing in the ears

  • shortness of breath or troubled breathing

  • sweating

  • unusual tiredness or weakness

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common
  • Difficult urination (more common with large doses taken over a prolonged period of time)

  • dryness of mouth, nose, or throat

  • nausea or vomiting

  • stomach upset or pain (more common with large doses taken over a prolonged period of time)

This medicine may cause your urine and/or stools to turn blue or blue-green. This is to be expected while you are taking this medicine.


Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Prosed EC resources


  • Prosed EC Use in Pregnancy & Breastfeeding
  • Prosed EC Drug Interactions
  • Prosed EC Support Group
  • 0 Reviews for Prosed EC - Add your own review/rating


  • Darcalma Concise Consumer Information (Cerner Multum)

  • Darcalma Prescribing Information (FDA)

  • Darpaz Prescribing Information (FDA)

  • Phosenamine Prescribing Information (FDA)

  • Phosphasal Prescribing Information (FDA)

  • Prosed/DS MedFacts Consumer Leaflet (Wolters Kluwer)

  • Urelle Prescribing Information (FDA)

  • Uribel Prescribing Information (FDA)

  • Urimax Delayed-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)

  • Urised MedFacts Consumer Leaflet (Wolters Kluwer)

  • Uritact-EC Delayed-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)

  • Ustell Prescribing Information (FDA)

  • Uta MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Prosed EC with other medications


  • Urinary Tract Infection

Ondansetron Soluble Film


Pronunciation: on-DAN-se-tron
Generic Name: Ondansetron
Brand Name: Zuplenz


Ondansetron Soluble Film is used for:

Preventing nausea and vomiting associated with chemotherapy, radiation treatment, or surgery. It may also be used for other conditions as determined by your doctor.


Ondansetron Soluble Film is a serotonin 5-HT3 receptor blocker. It works by blocking a chemical thought to be a cause of nausea and vomiting in certain situations (eg, chemotherapy).


Do NOT use Ondansetron Soluble Film if:


  • you are allergic to any ingredient in Ondansetron Soluble Film

  • you are taking apomorphine

  • you have a certain type of irregular heartbeat (congenital long QT syndrome)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Ondansetron Soluble Film:


Some medical conditions may interact with Ondansetron Soluble Film. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have had an allergic reaction to another serotonin 5-HT3 receptor blocker (eg, dolasetron, granisetron)

  • if you have liver problems, heart problems (eg, congestive heart failure, slow or irregular heartbeat, QT prolongation), or electrolyte problems (eg, low potassium or magnesium levels)

  • if you take medicines that may affect your heartbeat. Check with your doctor if you are unsure if any of your medicines may affect your heartbeat

Some MEDICINES MAY INTERACT with Ondansetron Soluble Film. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Apomorphine because the risk of its side effects may be increased by Ondansetron Soluble Film

  • Antineoplastic agents (eg, cyclophosphamide) or tramadol because their effectiveness may be decreased by Ondansetron Soluble Film

This may not be a complete list of all interactions that may occur. Ask your health care provider if Ondansetron Soluble Film may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Ondansetron Soluble Film:


Use Ondansetron Soluble Film as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • An extra patient leaflet is available with Ondansetron Soluble Film. Talk to your pharmacist if you have questions about this information.

  • Do not remove the film strip from the foil pouch until you are ready to take Ondansetron Soluble Film. Use the film strip immediately after opening the pouch. Do not store the removed film strip for future use.

  • Make sure that your hands are dry when you open the foil pouch.

  • To use Ondansetron Soluble Film, fold the pouch along the dotted line and tear it along the edge. Remove the film strip and place it on the top of your tongue. Once the strip dissolves, it can be swallowed with saliva. Ondansetron Soluble Film may be taken with or without liquid.

  • Do not chew or swallow Ondansetron Soluble Film whole.

  • Wash your hands after you use Ondansetron Soluble Film.

  • To prevent or reduce the possibility of nausea or vomiting, continue taking Ondansetron Soluble Film for the entire time recommended by your doctor even if you do not notice any nausea.

  • If you miss a dose of Ondansetron Soluble Film, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Ondansetron Soluble Film.



Important safety information:


  • Ondansetron Soluble Film may cause drowsiness or dizziness. These effects may be worse if you take it with alcohol or certain medicines. Use Ondansetron Soluble Film with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Ondansetron Soluble Film should be used with extreme caution in CHILDREN younger than 4 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Ondansetron Soluble Film while you are pregnant. It is not known if Ondansetron Soluble Film is found in breast milk. If you are or will be breast-feeding while you use Ondansetron Soluble Film, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Ondansetron Soluble Film:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; diarrhea; dizziness; drowsiness; headache; tiredness; weakness.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, throat, or tongue; wheezing; unusual hoarseness); chest or jaw pain, numbness of an arm or leg, or sudden, severe headache or vomiting; fainting; fast, slow, or irregular heartbeat; fever; seizures; severe or persistent dizziness; shortness of breath; skin tingling or numbness; stomach pain; trouble urinating; uncontrolled muscle movements; vision changes or loss.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Ondansetron side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include fainting; severe dizziness; slowed, irregular heartbeat; sudden, temporary blindness.


Proper storage of Ondansetron Soluble Film:

Store Ondansetron Soluble Film at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Keep the foil pouches in the carton. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Ondansetron Soluble Film out of the reach of children and away from pets.


General information:


  • If you have any questions about Ondansetron Soluble Film, please talk with your doctor, pharmacist, or other health care provider.

  • Ondansetron Soluble Film is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Ondansetron Soluble Film. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Ondansetron resources


  • Ondansetron Side Effects (in more detail)
  • Ondansetron Use in Pregnancy & Breastfeeding
  • Drug Images
  • Ondansetron Drug Interactions
  • Ondansetron Support Group
  • 81 Reviews for Ondansetron - Add your own review/rating


Compare Ondansetron with other medications


  • Alcohol Dependence
  • Gastroenteritis
  • Nausea/Vomiting
  • Nausea/Vomiting, Chemotherapy Induced
  • Nausea/Vomiting, Postoperative
  • Nausea/Vomiting, Radiation Induced
  • Obsessive Compulsive Disorder
  • Postanesthetic Shivering
  • Pruritus

Helmitin




Helmitin may be available in the countries listed below.


Ingredient matches for Helmitin



Piperazine

Piperazine citrate (a derivative of Piperazine) is reported as an ingredient of Helmitin in the following countries:


  • Ethiopia

International Drug Name Search

Wednesday, October 5, 2016

Dophilin




Dophilin may be available in the countries listed below.


Ingredient matches for Dophilin



Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Dophilin in the following countries:


  • Taiwan

International Drug Name Search

Domerajin




Domerajin may be available in the countries listed below.


Ingredient matches for Domerajin



Flucytosine

Flucytosine is reported as an ingredient of Domerajin in the following countries:


  • Japan

International Drug Name Search

Pyril DM Suspension



phenylephrine hydrochloride, pyrilamine maleate, and dextromethorphan hydrobromide

Dosage Form: oral suspension
Pyril DM

Suspension

Rx Only



Pyril DM Suspension Description


Pyril DM Suspension is an antihistamine/ nasal decongestant/antitussive combination for oral administration as a suspension. Each 5 mL (one teaspoonful) of the grape-flavored, purple-colored suspension for oral administration contains:








Phenylephrine HCl5 mg
Pyrilamine Maleate16 mg
Dextromethorphan HBr15 mg

Inactive ingredients: Citric acid, FD&C Blue No. 1, FD&C Red No. 40, glycerin, grape flavor, magnesium aluminum silicate, methylparaben, purified water, sucralose, monoammonium glycyrrhizinate, sodium benzoate, sodium citrate dihydrate, sucrose, xanthan gum and galloquinate.



Pyril DM Suspension - Clinical Pharmacology


Pyril DM Suspension combines the sympathomimetic decongestant effect of phenylephrine with the antihistaminic action of pyrilamine and the antitussive effect of dextromethorphan.



PHENYLEPHRINE


Phenylephrine is a decongestant which is a potent postsynaptic α-receptor agonist with little effect on β receptors of the heart. A direct action at receptors accounts for the greater part of its effects, only a small part being due to its ability to release norepinephrine. Phenylephrine has no effect on β-adrenergic receptors of the bronchi or peripheral blood vessels.


Phenylephrine has a mild central stimulant effect.



PYRILAMINE


Pyrilamine is an antihistamine, H1 receptor blocking agent belonging to the ethylenediamine class of antihistamines. H1-blocking drugs inhibit the actions of histamine on smooth muscle, capillary permeability, and can both stimulate and depress the central nervous system.


Pyrilamine also possesses anticholinergic and sedative properties.



DEXTROMETHORPHAN


Dextromethorphan is an antitussive agent and, unlike the isomeric levorphanol, it has no analgesic or addictive properties. The drug acts centrally and elevates the threshold for coughing. It is about equal to codeine in depressing the cough reflex. In therapeutic dosage dextromethorphan does not inhibit ciliary activity.



Indications and Usage for Pyril DM Suspension


Pyril DM Suspension is indicated for the symptomatic relief of coryza, nasal congestion, and cough associated with the common cold, sinusitis, allergic rhinitis, and other upper respiratory tract conditions. Appropriate therapy should be provided for the primary disease.



Contraindications


Pyril DM Suspension is contraindicated in patients sensitive to any of the ingredients or related compounds. Antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma.


Phenylephrine is contraindicated in patients with hypertension or with peripheral vascular insufficiency (ischemia may result with risk of gangrene or thrombosis of compromised vascular beds).


Pyril DM Suspension should not be used in patients receiving a monoamine oxidase inhibitor (MAOI) (see "PRECAUTIONS-DRUG INTERACTIONS").



Warnings


This product contains an antihistamine that may cause drowsiness and may have additive central nervous system (CNS) effects with alcohol or other CNS depressants (e.g., hypnotics, sedatives, tranquilizers). Antihistamines shoud be used with caution in patients with stenosing peptic ulcer, pyloroduodenal obstruction, and urinary bladder obstruction due to symptomatic prostatic hypertrophy and narrowing of the bladder neck.


Administration of dextromethorphan may be accompanied by histamine release and should be used with caution in atopic children.



Precautions



GENERAL


Antihistamines are more likely to cause dizziness, sedation, and hypotension in elderly patients, and therefore should be used with caution. Antihistamines may cause excitation, particularly in pediatric patients, but their combination with sympathomimetics may cause either mild stimulation or mild sedation. Use with caution in patients with hypertension, cardiovascular disease, hyperthyroidism, diabetes, or narrow angle glaucoma. Dextromethorphan should be used with caution in sedated patients, and in patients confined to the supine position.



INFORMATION FOR PATIENTS


Caution patients against drinking alcoholic beverages or engaging in potentially hazardous activities requiring alertness, such as driving a car or operating machinery, while using this product. Patients should be warned not to use this product if they are now taking a prescription monoamine oxidase (MAO) inhibitor (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAO inhibitor drug. If patients are uncertain whether a prescription drug contains an MAO inhibitor, they should be instructed to consult a health professional before taking this product.



DRUG INTERACTIONS


MAO inhibitors may prolong and intensify the anticholinergic effects of antihistamines and the overall effects of sympathomimetic agents. Patients may develop hyperpyrexia, hypotension, nausea, myoclonic leg jerks, and coma following coadministration of MAO inhibitors and dextromethorphan. Thus, concomitant administration of Pyril DM Suspension and MAO inhibitors should be avoided (see " CONTRAINDICATIONS").



CARCINOGENESIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY


No long-term animal studies have been performed with Pyril DM Suspension.



PREGNANCY


Teratogenic Effects

Pregnancy Category C


Animal reproduction studies have not been conducted with Pyril DM Suspension. It is also not known whether Pyril DM Suspension can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Pyril DM Suspension should be given to a pregnant woman only if clearly needed.



LABOR AND DELIVERY


Administration of phenylephrine to patients in late pregnancy or labor may cause fetal anoxia or bradycardia by increasing contractility of the uterus and decreasing uterine blood flow.



NURSING MOTHERS


Because of the higher risk of intolerance of antihistamines in small infants generally, and in newborns and prematures in particular, Pyril DM Suspension should not be administered to a nursing mother.



Adverse Reactions


The most common effects associated with antihistamines have been drowsiness, sedation, dryness of mucous membranes, and gastrointestinal effects. Serious side effects with oral antihistamines, sympathomimetics, and antitussives have been rare. Other adverse reactions may include:


Dermatologic - urticaria, drug rash, photosensitivity, pruritus.


Cardiovascular - hypotension, hypertension, cardiac arrhythmias, palpitations.


Central Nervous System (CNS) - disturbed coordination, tremor, irritability, insomnia, visual disturbances, weakness, nervousness, convulsion, headache, euphoria, and dysphoria.


Genitourinary - urinary frequency, difficult urination.


Gastrointestinal - epigastric discomfort, anorexia, nausea, vomiting, diarrhea, constipation.


Respiratory - tightness of chest and wheezing, shortness of breath.


Hematologic - hemolytic anemia, thrombocytopenia, agranulocytosis.



Overdosage



SIGNS AND SYMPTOMS


May vary from CNS depression to stimulation (restlessness to convulsions). Antihistamine overdosage in young children may lead to convulsions and death. Atropine-like signs and symptoms may be prominent. Dextromethorphan may produce central excitement and mental confusion. Very high doses of dextromethorphan may produce respiratory depression.



TREATMENT


Induce vomiting if it has not occurred spontaneously. Precautions must be taken against aspiration especially in infants, children, and comatose patients. If gastric lavage is indicated, isotonic or half-isotonic saline solution is preferred. Stimulants should not be used. If hypotension is a problem, vasopressor agents may be considered.



Pyril DM Suspension Dosage and Administration



Pyril DM Suspension


Administer the recommended dose every 8 hours. Adults and Children over 12 years of age – 5 to 10 mL (1 to 2 teaspoonfuls); 6 to 12 years of age – 5 mL (1 teaspoonful); 2 to 6 years of age – 2.5 mL (1/2 teaspoonful); Under 2 years of age – Consult a physician.


NOTE: The maleate salt of pyrilamine, the hydrochloride salt of phenylephrine, and the hydrobromide salt of dextromethorphan are provided in a suspension by means of a patented manufacturing process.



How is Pyril DM Suspension Supplied


Pyril DM Suspension: is available in a grape-flavored, purple-colored suspension.


NDC No.: 44183-210-16 – 16 fl. oz. bottles.



Store at controlled room temperature, 20°-25°C (68°-77°F).


Dispense in a tight, light-resistant container (USP/NF) with a child-resistant closure.



Patent Protected


Rx Only


Manufactured for:

Macoven Pharmaceuticals, LLC

Magnolia, TX 77354


Int 3/09

547-60416-2



PRINCIPAL DISPLAY PANEL - 473 mL Bottle Label


MACOVEN

PHARMACEUTICALS, LLC


NDC 44183-210-16


PYRIL DM


Each 5 mL (one teaspoonful)

for oral administration contains:








Pyrilamine Maleate16 mg
Phenylephrine HCl5 mg
Dextromethorphan HBr15 mg

SUSPENSION


Rx only


16 fl. oz. (473mL)










PYRIL DM 
phenylephrine hydrochloride, pyrilamine maleate, and dextromethorphan hydrobromide  suspension










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)44183-210
Route of AdministrationORALDEA Schedule    














Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE)PHENYLEPHRINE HYDROCHLORIDE5 mg  in 5 mL
PYRILAMINE MALEATE (PYRILAMINE)PYRILAMINE MALEATE16 mg  in 5 mL
DEXTROMETHORPHAN HYDROBROMIDE (DEXTROMETHORPHAN)DEXTROMETHORPHAN HYDROBROMIDE15 mg  in 5 mL


































Inactive Ingredients
Ingredient NameStrength
CITRIC ACID MONOHYDRATE 
FD&C BLUE NO. 1 
FD&C RED NO. 40 
GLYCERIN 
GRAPE 
MAGNESIUM ALUMINUM SILICATE 
METHYLPARABEN 
WATER 
SUCRALOSE 
GLYCYRRHIZIN, AMMONIATED 
SODIUM BENZOATE 
SODIUM CITRATE 
SUCROSE 
XANTHAN GUM 
TANNIC ACID 


















Product Characteristics
ColorPURPLEScore    
ShapeSize
FlavorGRAPEImprint Code
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
144183-210-16473 mL In 1 BOTTLENone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
UNAPPROVED DRUG OTHER01/04/2010


Labeler - Macoven Pharmaceuticals (832591965)
Revised: 12/2010Macoven Pharmaceuticals

More Pyril DM Suspension resources


  • Pyril DM Suspension Side Effects (in more detail)
  • Pyril DM Suspension Dosage
  • Pyril DM Suspension Use in Pregnancy & Breastfeeding
  • Pyril DM Suspension Drug Interactions
  • 0 Reviews for Pyril DM - Add your own review/rating


Compare Pyril DM Suspension with other medications


  • Cold Symptoms
  • Hay Fever
  • Sinusitis